Horton, C., Davies, T., Lahiri, P., Sachamitr, P., & Fairchild, P. (2019). iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Wiley.
Chicago-čujuhus (17. p.)Horton, C., TJ Davies, P. Lahiri, P. Sachamitr, juo PJ Fairchild. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
MLA-čujuhus (9. p.)Horton, C., et al. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.